Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment Decision Intervention for Veterans With Prostate Cancer
This study has been completed.
Study NCT00012935   Information provided by Department of Veterans Affairs
First Received: March 14, 2001   Last Updated: October 31, 2008   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

March 14, 2001
October 31, 2008
 
 
 
Complete list of historical versions of study NCT00012935 on ClinicalTrials.gov Archive Site
 
 
 
Treatment Decision Intervention for Veterans With Prostate Cancer
Treatment Decision Intervention for Veterans With Prostate Cancer

Newly diagnosed localized prostate cancer patients face difficult decisions about treatment and management; including radiation therapy, radical prostatectomy, brachytherapy, and observation. Previous studies have cited patient preference and physician recommendation for treatment as major roles in treatment decisions.

Background:

Newly diagnosed localized prostate cancer patients face difficult decisions about treatment and management; including radiation therapy, radical prostatectomy, brachytherapy, and observation. Previous studies have cited patient preference and physician recommendation for treatment as major roles in treatment decisions.

Objectives:

This grant will be used to develop and evaluate a decision analysis based intervention to improve decision-making among veterans with newly diagnosed localized prostate cancer. While the ultimate goal of this study is to improve decision-making among these patients, factors influencing physician recommendations for treatment will be sought. The former will be achieved by evaluating the efficacy of providing physicians with information incorporating patient preference for alternative health states with probabilities of treatment outcomes. Factors influencing physician recommendations for treatment will be determined through qualitative interviews with physicians.

Methods:

Patients were accrued at the VA Chicago Health Care System Lakeside Urology Clinic. Upon consent for participation in the study, comorbidities, histologic grade of the biopsy, and age were obtained for 13 patients with newly diagnosed localized prostate cancer. Using a standard gamble technique, interviewers obtained patient utilities for 5 distinct health states related to prostate cancer treatment. Clinical and pathologic characteristics were incorporated into the decision analytic model, and the derived quality-adjusted life expectancies (QALEs) were shared with the treating urologist before patient-physician discussion of treatment options. The feasibility of the decision analytic intervention and unbiased estimates of the impact of the intervention was evaluated. The long-range objective of this proposal is to design an intervention for veterans that increases physician understanding of patient treatment preferences and patient understanding of choices in prostate cancer treatment.

Status:

Completed

 
Interventional
Other, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Prostate Cancer
Behavioral: Help with decision making on prostate cancer treatment
 
Knight SJ, Nathan DP, Siston AK, Kattan MW, Elstein AS, Collela KM, Wolf MS, Slimack NS, Bennett CL, Golub RM. Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. Clin Prostate Cancer. 2002 Sep;1(2):105-14.

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
100
December 2001
 

Inclusion Criteria:

1) biopsy confirmed diagnosis of localized prostate cancer; 2) newly diagnosed-no prior treatment (including watchful waiting) or discussion with their prior physicians about treatment options; 3) no previous neoplasms in the last five years, with the exception of basal cell cancer of the skin; 4) speak english; 5) no major psychiatric disorder that would preclude their participation; 6) be between 50 and 80 years of age.

Exclusion Criteria:

Male
50 Years to 80 Years
No
 
United States
 
 
NCT00012935
Bennett, Charles - Principal Investigator, Department of Veterans Affairs
 
Department of Veterans Affairs
 
Principal Investigator: Charles L. Bennett, MD PhD MPP Jesse Brown VAMC (Lakeside CBOC)
Department of Veterans Affairs
January 2005

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.